ArticleVaccine2019

Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model.

Soledad Mac Keon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.